Pages that link to "Q53806651"
Jump to navigation
Jump to search
The following pages link to Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response. (Q53806651):
Displaying 12 items.
- Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4 (Q36661584) (← links)
- Inducible T Cell Kinase Regulates the Acquisition of Cytolytic Capacity and Degranulation in CD8+ CTLs (Q40327708) (← links)
- Depletion of major pathogenic cells in asthma by targeting CRTh2. (Q40517997) (← links)
- Ibrutinib treatment improves T cell number and function in CLL patients (Q42909982) (← links)
- The PI3K Pathway in Human Disease (Q46546002) (← links)
- Interleukin-2-Inducible T-Cell Kinase Deficiency-New Patients, New Insight? (Q54977055) (← links)
- The Cell Research Trends of Asthma: A Stem Frequency Analysis of the Literature (Q57167816) (← links)
- A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation (Q64090676) (← links)
- Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells (Q89557160) (← links)
- An efficient hybrid feature selection method to identify potential biomarkers in common chronic lung inflammatory diseases (Q96428233) (← links)
- BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy (Q97520951) (← links)
- Kinase inhibition in autoimmunity and inflammation (Q100737257) (← links)